The pharmaceutical company Moderna climbed the Nasdaq after US authorities approved the use of the third vaccine dose for anyone over 18 years of age.
–
It was mixed for the leading indices in the US on Friday. Uncertainty following the shutdown in Austria weighed on markets, while technology stocks rose.
This is what it looked like on Wall Street at closing at 22 Norwegian time:
- The S&P 500 ended down 0.14 percent
- Nasdaq rose 0.40 percent
- The Dow Jones fell 0.75 percent
Austria and infrastructure package
The development on Wall Street comes after European stock markets have fallen from around lunchtime. Fears of new closures have increased after Austria, as the first country in Europe, announced a new shutdown from Monday.
At 3:45 p.m., Bloomberg reports that the House of Representatives has approved President Joe Biden’s package for infrastructure and climate action.
The package is worth about 1,750 billion dollars, and will now be considered in the Senate. This is the third package in the president’s “Build Back Better” program.
Rise after vaccine approval
The pharmaceutical companies Pfizer and Moderna rose after the US Drug Administration approved a third dose of vaccine against the coronavirus for all adults. However, the Pfizer share has reversed during the day, and is down 1.15 percent at the close.
– This emergency approval comes at a critical time. We are on our way into the winter season and are facing increasing infection rates and corona admissions, all over the country, says Moderna’s CEO Stephane Bancel, according to NTB.
The Moderna share was up 4.92 percent at the close.
–
